health careMarket Research Newsmedical devicesNews

Global Internal Neuromodulation Device Market Size, Share, Growth, Product Type, Industry Trends & Forecast to 2024: Medtronic, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation, Cyberonics

The following Internal Neuromodulation Device market report is a study of the Healthcare industry.

The report is an encapsulation of all the data a new player needs in order to excel the Internal Neuromodulation Device market, like the company profiles of the top players and brands that are dominating the market with their strategic moves like product launches, researches, joint ventures, mergers, and accusations which in turn affect the sales, import, export, revenue and CAGR values.

Moreover, this Internal Neuromodulation Device report also contains a deep knowledge of Internal Neuromodulation Device market’s definition, classifications, applications, and engagements while explaining the drivers and restraints of the Internal Neuromodulation Device market derived from SWOT analysis.

The Global Internal Neuromodulation Market is expected to reach USD  12.18 billion by 2024, from 4.12 billion in 2018 growing at the CAGR of 14.5% in the forecast period 2019 to 2024. Download Free Sample Report https://databridgemarketresearch.com/request-a-sample/?dbmr=global-internal-neuromodulation-devices-market

Key Players: Global Internal Neuromodulation Devices Market

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Nevro Corp
  • Cyberonics, Inc.
  • Neuros Medical
  • Inspire Medical Systems, Inc
  • SPR Therapeutics
  • Synapse Biomedical Inc
  • NeuroSigma Inc
  • NeuroPace Inc.
  • Neuronetics
  • BioControl Medical
  • Soterix Medical Inc
  • DynaMD
  • Integer Holdings Corporation
  • LivaNova PLC
  • Bioness Inc
  • ReShape Lifesciences.Inc

FACTORS DRIVING GROWTH OF THE GLOBAL INTERNAL NEUROMODULATION DEVICES MARKET

Increasing prevalence of neurological diseases:

According to the Alzheimer’s Association in 2017, 5.5 million Americans had Alzheimer and about 5.3 million of this patient population’s age was 65 years or more. According to Alzheimer disease international, in 2015 there were an estimated 46.8 million people living with Alzheimer worldwide this number is expected to be double every 20 years reaching 75 million in 2030 and 131.5 million by 2050.

According to national center for biotechnology information, about 60,000 Americans are diagnosed with Parkinson’s every year. An estimated 7 million to 10 million people worldwide have Parkinson’s disease. The prevalence of this disease is 1,900 per 100,000 in those who are above 80 years of age and 41 per 100,000 in fourth decade of life.

Epilepsy is the chronic disorder of the brain which affects almost all ages. According to world health organization, 50 million people worldwide have epilepsy and this number is estimated to increase in coming years which makes it one of the most common neurological disorders.

Therefore, with the increase in disease condition such as Alzheimer’s, Parkinson’s, epilepsy, eschemia, the global internal neuromodulation devices market is expected to achieve a growth in future.

Table of Contents:Global Internal Neuromodulation Devices Market

Chapter 1: Industry Overview

Chapter 2: Production Market Analysis

Chapter 3: Sales Market Analysis

Chapter 4: Consumption Market Analysis

Chapter 5: Production, Sales and Consumption Market Comparison Analysis

Chapter 6: Major Manufacturers Production and Sales Market Comparison Analysis

Chapter 7: Major Source Analysis

Chapter 8: Major Application Analysis

Chapter 9: Industry Chain Analysis

Chapter 10: Global and Regional Market Forecast

Chapter 11: Major Manufacturers Analysis

Chapter 12: New Project Investment Feasibility Analysis

Chapter 13: Conclusions

Chapter 14: Appendix

Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-internal-neuromodulation-devices-market

Segmentation:Global Internal Neuromodulation Devices Market

The global market for internal neuromodulation devices by the following sub-categories is presented

By Product Type

  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Vagus Nerve Stimulator
  • Sacral Nerve Stimulator
  • Gastric Nerve Stimulator

By Indication of Usage

  • Failed Back Surgery Syndrome
  • Conditional Regional Pain Syndrome
  • Eschemia
  • Parkinson’s Disease
  • Alzheimers
  • Urinary Incontinence
  • Faecal Incontinenece
  • Epilepsy
  • Gastroparesis
  • Others

By Lead Type

  • Percutaneous
  • Paddle Lead

By Battery Type

  • Primary
  • Rechargeable

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Global Internal Neuromodulation Devices Market, By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), By Lead Type (Percutaneous, Paddle Lead), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis), By Battery Type (Primary, Rechargeable), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America, Rest of the World) – Trends and Forecast to 2024

Speak To Author https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-internal-neuromodulation-devices-market

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *